Bausch And Lomb Company Profile
✉ Email this page to a colleague
What is the competitive landscape for BAUSCH AND LOMB, and what generic alternatives to BAUSCH AND LOMB drugs are available?
BAUSCH AND LOMB has eighty-three approved drugs.
There are forty-nine US patents protecting BAUSCH AND LOMB drugs.
There are four hundred and seventy-six patent family members on BAUSCH AND LOMB drugs in forty-eight countries and eighty-two supplementary protection certificates in fifteen countries.
Summary for Bausch And Lomb
| International Patents: | 476 |
| US Patents: | 49 |
| Tradenames: | 76 |
| Ingredients: | 58 |
| NDAs: | 83 |
Drugs and US Patents for Bausch And Lomb
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bausch And Lomb | ACETIC ACID 2% IN AQUEOUS ALUMINUM ACETATE | acetic acid, glacial; aluminum acetate | SOLUTION/DROPS;OTIC | 040063-001 | Feb 25, 1994 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| Bausch And Lomb | VYZULTA | latanoprostene bunod | SOLUTION/DROPS;OPHTHALMIC | 207795-001 | Nov 2, 2017 | RX | Yes | Yes | 7,273,946 | ⤷ Subscribe | Y | Y | ⤷ Subscribe | ||
| Bausch And Lomb Inc | XIIDRA | lifitegrast | SOLUTION/DROPS;OPHTHALMIC | 208073-001 | Jul 11, 2016 | AB | RX | Yes | Yes | 8,927,574 | ⤷ Subscribe | Y | ⤷ Subscribe | ||
| Bausch And Lomb Inc | XIIDRA | lifitegrast | SOLUTION/DROPS;OPHTHALMIC | 208073-001 | Jul 11, 2016 | AB | RX | Yes | Yes | 8,168,655 | ⤷ Subscribe | ⤷ Subscribe | |||
| Bausch And Lomb Inc | XIIDRA | lifitegrast | SOLUTION/DROPS;OPHTHALMIC | 208073-001 | Jul 11, 2016 | AB | RX | Yes | Yes | 7,745,460 | ⤷ Subscribe | Y | Y | ⤷ Subscribe | |
| Bausch And Lomb | CARTEOLOL HYDROCHLORIDE | carteolol hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 075546-001 | Jan 20, 2000 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| Bausch And Lomb | TROPICAMIDE | tropicamide | SOLUTION/DROPS;OPHTHALMIC | 040064-001 | Jul 27, 1994 | AT | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Bausch And Lomb
Paragraph IV (Patent) Challenges for BAUSCH AND LOMB drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Ophthalmic Solution | 0.07% | ➤ Subscribe | 2013-07-26 |
| ➤ Subscribe | Ophthalmic Solution | 0.5% | ➤ Subscribe | 2012-10-19 |
| ➤ Subscribe | Ophthalmic Solution | 1.5% | ➤ Subscribe | 2013-09-09 |
International Patents for Bausch And Lomb Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 2013130577 | ⤷ Subscribe |
| South Korea | 101817928 | ⤷ Subscribe |
| Mexico | 2020006004 | ⤷ Subscribe |
| South Korea | 20210093394 | ⤷ Subscribe |
| Spain | 2924645 | ⤷ Subscribe |
| Hong Kong | 1210041 | ⤷ Subscribe |
| European Patent Office | 2276508 | ⤷ Subscribe |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Bausch And Lomb Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 2444079 | C02444079/01 | Switzerland | ⤷ Subscribe | PRODUCT NAME: LIFITEGRAST; REGISTRATION NO/DATE: SWISSMEDIC-ZULASSUNG 66850 19.12.2018 |
| 0957929 | 132006901428637 | Italy | ⤷ Subscribe | PRODUCT NAME: PEGAPTANIB SODICO(MACUGEN); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/05/325/001, 20060131 |
| 0364417 | SPC/GB97/014 | United Kingdom | ⤷ Subscribe | PRODUCT NAME: LATANOPROST (I.E. 13,14-DIHYDRO-17-PHENYL-18,19,20-TRINOR-PGF-ALPHA-ISOPROPYLESTER); NAT. REGISTRATION NO/DATE: 00032/0220 19961216; FIRST REGISTRATION: SE 12716 19960718; SPC EXTENSION AUTHORISATION: PL00057/1057-008 20101216 |
| 1586316 | C 2011 004 | Romania | ⤷ Subscribe | PRODUCT NAME: BROMFENAC, SARURILE SI HIDRATII SAI ACCEPTABILI FARMACEUTICACID 2-[2-AMINO-3-(4-BROMOBENZOIL)FENILACETIC; NATIONAL AUTHORISATION NUMBER: RO EU/1/11/692/001; DATE OF NATIONAL AUTHORISATION: 20110518; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EMEA EU/1/11/692/001; DATE OF FIRST AUTHORISATION IN EEA: 20110518 |
| 0364417 | 9690031-1 | Sweden | ⤷ Subscribe | PRODUCT NAME: LATANOPROST |
| 3461484 | 132021000000068 | Italy | ⤷ Subscribe | PRODUCT NAME: COMBINAZIONE DI LATANOPROST E NETARSUDIL(ROCLANDA); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/20/1502, 20210108 |
| 1586316 | C300494 | Netherlands | ⤷ Subscribe | PRODUCT NAME: BROMFENAC, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT OF HYDRAAT; REGISTRATION NO/DATE: EU/1/11/692/001 20110518 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
